Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-10

Clinical Trial Update: Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing etoricoxib to ibuprofen for dysmenorrhea completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Organon and Co | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED | Results posted: 2013-07-10